drugset / Trial / NCT03189537
Study of Post-Exposure Ingavirin® Prophylaxis of Influenza and Acute Respiratory Viral Infections
RandomizedParallel-groupTriple-blindPrevention
Summary
The purpose of the study was to evaluate efficacy of prophylactic Ingavirin intake by people having contact with sick people infected with influenza and other acute respiratory viral infections
Timeline
- Start
- 2010-10-03
- Primary completion
- 2011-04-19
- Completion
- 2011-10-10
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Ingavirin | Small molecule | 90 mg | Oral |